{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:44:47Z","timestamp":1793835887822,"version":"4.6.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T00:00:00Z","timestamp":1507593600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T00:00:00Z","timestamp":1507593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA012582"],"award-info":[{"award-number":["CA012582"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA76489"],"award-info":[{"award-number":["CA76489"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1245\/s10434-017-6072-3","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T13:36:16Z","timestamp":1507642576000},"page":"3991-4000","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":135,"title":["Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases"],"prefix":"10.1245","volume":"24","author":[{"name":"MMAIT-IV Clinical Trial Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark B.","family":"Faries","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Mozzillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Kashani-Sabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"DeConti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey E.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Huth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angus","family":"Dalgleish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pertschuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Nardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Elashoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Gammon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald L.","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,10]]},"reference":[{"issue":"4","key":"6072_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/(SICI)1096-9098(199908)71:4<209::AID-JSO1>3.0.CO;2-2","volume":"71","author":"D Ollila","year":"1999","unstructured":"Ollila D, Hsueh E, Stern S, Morton D. Metastasectomy for recurrent stage IV melanoma. J Surg Oncol. 1999;71(4):209\u201313.","journal-title":"J Surg Oncol."},{"key":"6072_CR2","doi-asserted-by":"crossref","unstructured":"Ozao-Choy J, Lee DJ, Faries MB. Melanoma vaccines: mixed past, promising future. Surg Clin North Am. 2014;94(5):1017\u201330, viii.","DOI":"10.1016\/j.suc.2014.07.005"},{"issue":"8","key":"6072_CR3","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1245\/s10434-012-2398-z","volume":"19","author":"JH Howard","year":"2012","unstructured":"Howard JH, Thompson JF, Mozzillo N, et al. Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I). Ann Surg Oncol. 2012;19(8):2547\u201355.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"6072_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3322\/canjclin.49.2.101","volume":"49","author":"D Morton","year":"1999","unstructured":"Morton D, Ollila D, Hsueh E, Essner R, Gupta R. Cytoreductive surgery and adjuvant immunotherapy: a new management paradigm for metastatic melanoma. CA Cancer J Clin. 1999;49(2):101\u201316.","journal-title":"CA Cancer J Clin."},{"issue":"23","key":"6072_CR5","doi-asserted-by":"publisher","first-page":"4549","DOI":"10.1200\/JCO.2002.01.151","volume":"20","author":"E Hsueh","year":"2002","unstructured":"Hsueh E, Essner R, Foshag L, et al. Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccine. J Clin Oncol. 2002;20(23):4549\u201354.","journal-title":"J Clin Oncol."},{"issue":"2","key":"6072_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/jso.21903","volume":"104","author":"N Wasif","year":"2011","unstructured":"Wasif N, Bagaria SP, Ray P, Morton DL. Does metastasectomy improve survival in patients with Stage IV melanoma? A cancer registry analysis of outcomes. J Surg Oncol. 2011;104(2):111\u20135.","journal-title":"J Surg Oncol."},{"issue":"2","key":"6072_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/00001622-200403000-00013","volume":"16","author":"SL Wong","year":"2004","unstructured":"Wong SL, Coit DG. Role of surgery in patients with stage IV melanoma. Curr Opin Oncol. 2004;16(2):155\u201360.","journal-title":"Curr Opin Oncol."},{"key":"6072_CR8","doi-asserted-by":"crossref","unstructured":"Essner R, Lee JH, Wanek LA, Itakura H, Morton DL. Contemporary surgical treatment of advanced-stage melanoma. Arch Surg. 2004;139(9):961\u20136; discussion 6\u20137.","DOI":"10.1001\/archsurg.139.9.961"},{"issue":"3","key":"6072_CR9","first-page":"295","volume":"115","author":"C Karakousis","year":"1994","unstructured":"Karakousis C, Velez A, Driscoll D, Takita H. Metastasectomy in malignant melanoma. Surgery. 1994;115(3):295\u2013302.","journal-title":"Surgery."},{"issue":"9","key":"6072_CR10","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1002\/1097-0142(20001101)89:9<1983::AID-CNCR15>3.3.CO;2-J","volume":"89","author":"T Meyer","year":"2000","unstructured":"Meyer T, Merkel S, Goehl J, Hohenberger W. Surgical therapy for distant metastases of malignant melanoma. Cancer. 2000;89(9):1983\u201391.","journal-title":"Cancer"},{"issue":"20","key":"6072_CR11","doi-asserted-by":"publisher","first-page":"4740","DOI":"10.1002\/cncr.26111","volume":"117","author":"JA Sosman","year":"2011","unstructured":"Sosman JA, Moon J, Tuthill RJ, et al. A phase 2 trial of complete resection for stage IV melanoma: results of Southwest Oncology Group Clinical Trial S9430. Cancer. 2011;117(20):4740\u20136.","journal-title":"Cancer."},{"issue":"4","key":"6072_CR12","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0022-5223(19)34957-8","volume":"103","author":"D Harpole","year":"1992","unstructured":"Harpole D, Johnson C, Wolfe W, George S, Seigler H. Analysis of 945 cases of pulmonary metastatic melanoma. J Thorac Cardiovasc Surg. 1992;103(4):743\u20138.","journal-title":"J Thorac Cardiovasc Surg."},{"key":"6072_CR13","unstructured":"American Joint Committee on Cancer. AJCC Cancer Staging Manual, 5th edn. Philadelphia: Lippincott-Raven; 1997."},{"issue":"4","key":"6072_CR14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/00000658-199210000-00010","volume":"216","author":"D Morton","year":"1992","unstructured":"Morton D, Foshag L, Hoon D, et al. Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine. Ann Surg. 1992;216(4):463\u201382.","journal-title":"Ann Surg."},{"issue":"9","key":"6072_CR15","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1200\/JCO.1998.16.9.2913","volume":"16","author":"E Hsueh","year":"1998","unstructured":"Hsueh E, Gupta R, Qi K, Morton D. Correlation of specific immune responses with survival in melanoma patients with distant metastases receiving polyvalent melanoma cell vaccine. J Clin Oncol. 1998;16(9):2913\u201320.","journal-title":"J Clin Oncol."},{"key":"6072_CR16","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1002\/(SICI)1097-0142(19990515)85:10<2160::AID-CNCR10>3.0.CO;2-0","volume":"85","author":"E Hsueh","year":"1999","unstructured":"Hsueh E, Nathanson L, Foshag L, et al. Active specific immunotherapy with polyvalent melanoma cell vaccine for patients with in-transit melanoma metastases. Cancer. 1999;85:2160\u20139.","journal-title":"Cancer."},{"key":"6072_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1749-6632.1993.tb44002.x","volume":"690","author":"D Morton","year":"1993","unstructured":"Morton D, Hoon D, Nizze J, et al. Polyvalent melanoma vaccine improves survival of patients with metastatic melanoma. Ann NY Acad Sci. 1993;690:120\u201334.","journal-title":"Ann NY Acad Sci."},{"issue":"3","key":"6072_CR18","first-page":"193","volume":"181","author":"A Barth","year":"1995","unstructured":"Barth A, Wanek L, Morton D. Prognositic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg. 1995;181(3):193\u2013201.","journal-title":"J Am Coll Surg."},{"issue":"7","key":"6072_CR19","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1245\/s10434-013-2881-1","volume":"20","author":"KP Wevers","year":"2013","unstructured":"Wevers KP, Hoekstra HJ. Stage IV melanoma: completely resectable patients are scarce. Ann Surg Oncol. 2013;20(7):2352\u20136.","journal-title":"Ann Surg Oncol."},{"issue":"7","key":"6072_CR20","first-page":"744","volume":"131","author":"AH Paterson","year":"1984","unstructured":"Paterson AH, Willans DJ, Jerry LM, Hanson J, McPherson TA. Adjuvant BCG immunotherapy for malignant melanoma. Can Med Assoc J. 1984;131(7):744\u20138.","journal-title":"Can Med Assoc J."},{"issue":"5","key":"6072_CR21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1056\/NEJM197601292940501","volume":"294","author":"F Eilber","year":"1976","unstructured":"Eilber F, Morton D, Holmes E, Sparks F, Ramming K. Adjuvant immunotherapy with BCG in treatment of regional lymph node metastases from malignant melanoma. N Engl J Med. 1976;294(5):237\u201340.","journal-title":"N Engl J Med."},{"issue":"8","key":"6072_CR22","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1002\/cncr.20166","volume":"100","author":"SS Agarwala","year":"2004","unstructured":"Agarwala SS, Neuberg D, Park Y, Kirkwood JM. Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group. Cancer. 2004;100(8):1692\u20138.","journal-title":"Cancer."},{"issue":"1","key":"6072_CR23","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ejca.2004.09.023","volume":"41","author":"KF Kolmel","year":"2005","unstructured":"Kolmel KF, Grange JM, Krone B, et al. Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. A European Organization for Research and Treatment of Cancer cohort study on 542 patients. Eur J Cancer. 2005;41(1):118\u201325.","journal-title":"Eur J Cancer."},{"issue":"1","key":"6072_CR24","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ejca.2004.08.010","volume":"41","author":"B Krone","year":"2005","unstructured":"Krone B, Kolmel KF, Henz BM, Grange JM. Protection against melanoma by vaccination with Bacille Calmette-Guerin (BCG) and\/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological control. Eur J Cancer. 2005;41(1):104\u201317.","journal-title":"Eur J Cancer."},{"issue":"4","key":"6072_CR25","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/00000658-197410000-00029","volume":"180","author":"D Morton","year":"1974","unstructured":"Morton D, Eilber F, Holmes E, et al. BCG immunotherapy of malignant melanoma: summary of a seven-year experience. Ann Surg. 1974;180(4):635\u201343.","journal-title":"Ann Surg."},{"issue":"9","key":"6072_CR26","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1097\/CJI.0b013e31827457bd","volume":"35","author":"TB Kidner","year":"2012","unstructured":"Kidner TB, Morton DL, Lee DJ, et al. Combined intralesional Bacille Calmette-Guerin (BCG) and topical imiquimod for in-transit melanoma. J Immunother. 2012;35(9):716\u201320.","journal-title":"J Immunother."},{"issue":"8","key":"6072_CR27","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi FS, O\u2019Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363(8):711\u201323.","journal-title":"N Engl J Med."},{"issue":"9","key":"6072_CR28","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1002011","volume":"363","author":"KT Flaherty","year":"2010","unstructured":"Flaherty KT, Puzanov I, Kim KB, et al. Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med. 2010;363(9):809\u201319.","journal-title":"N Engl J Med."},{"key":"6072_CR29","doi-asserted-by":"crossref","unstructured":"Wolchok JD, Kluger H, Callahan MK, et al. Nivolumab plus ipilimumab in advanced melanoma. N Engl J Med. 369(2):122\u201333.","DOI":"10.1056\/NEJMoa1302369"},{"issue":"2","key":"6072_CR30","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1056\/NEJMoa1305133","volume":"369","author":"O Hamid","year":"2013","unstructured":"Hamid O, Robert C, Daud A, et al. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. N Engl J Med. 2013;369(2):134\u201344.","journal-title":"N Engl J Med."},{"issue":"4","key":"6072_CR31","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/(SICI)1096-9098(199812)69:4<206::AID-JSO3>3.0.CO;2-N","volume":"69","author":"D Ollila","year":"1999","unstructured":"Ollila D, Stern S, Morton D. Tumor doubling time: a selection factor for pulmonary resection of metastatic disease. J Surg Oncol. 1999;69(4):206\u201311.","journal-title":"J Surg Oncol."},{"issue":"8","key":"6072_CR32","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1007\/s10434-001-0658-4","volume":"8","author":"T Wood","year":"2001","unstructured":"Wood T, DiFronzo A, Rose M, et al. Does complete resection of melanoma metastatic to solid intraabdominal organs improve survival? Ann Surg Oncol. 2001;8(8):658\u201362.","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-017-6072-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-017-6072-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-017-6072-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T01:46:32Z","timestamp":1659577592000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-017-6072-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,10]]},"references-count":32,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["6072"],"URL":"https:\/\/doi.org\/10.1245\/s10434-017-6072-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,10]]},"assertion":[{"value":"2 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2017","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}